Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amaurys del Río-Martín"'
Autor:
Carmen M Valenzuela-Silva, Elizeth García-Iglesias, José I Fernández-Montequín, Amaurys del Río-Martín, Isis Belkis Yera Alos, Ángela D. Tuero-Iglesias, Odalys González-Díaz, Pedro Lopez-Saura
Publikováno v:
Diabetes Care
OBJECTIVE To determine if partial wound closure surrogate markers proposed for neuropathic, small diabetic foot ulcers (DFUs) can be extended to advanced lesions and if the development of granulation tissue can be used to predict complete healing. RE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::601c6391d0c5aa14e57248849eb1cda0
https://doi.org/10.2337/dc12-1323
https://doi.org/10.2337/dc12-1323
Autor:
Odalys González-Díaz, José I Fernández-Montequín, Pedro Lopez-Saura, Ernesto López-Mola, Luis Herrera-Martínez, Boris Acevedo-Castro, Isis B Yera-Alos, Amaurys del Río-Martín, Jorge Berlanga-Acosta, Carmen M Valenzuela-Silva
Publikováno v:
Advances in Pharmacoepidemiology & Drug Safety.
The intralesional injection of recombinant human epidermal growth factor (rhEGF) has been recently approved and introduced in several countries for the treatment of advanced diabetic foot ulcers (DFU), based on the results of five exploratory and one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6307ec5f2b0a81df656958d0775d37b2
https://doi.org/10.4172/2167-1052.1000128
https://doi.org/10.4172/2167-1052.1000128
Autor:
Odalys González-Díaz, Amaurys del Río-Martín, José I Fernández-Montequín, Pedro Lopez-Saura, William Savigne, Lourdes Morejón-Vega, Ernesto López-Mola, Jorge Berlanga-Acosta, Carmen M Valenzuela-Silva, Boris Acevedo-Castro, Luis Herrera-Martínez
Publikováno v:
Global Perspective on Diabetic Foot Ulcerations
Foot ulceration is among the most significant complications of diabetes. It is estimated that 15% of the diabetic patients develop ulcers at some point in their lives (Reiber, 1996). The therapeutic management of a diabetic patient carrying a diabeti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7998c97c16aa87aa26c0cbf08b61078a
https://doi.org/10.5772/28150
https://doi.org/10.5772/28150
Autor:
Nelia Martin Olazábal, Héctor Hernández Hernández, Nelvis Figueroa Baile, Leovaldo Alvarez Falcon, Arístides Aguilar Betancourt, Carmen Valenzuela Silva, Evelyn Pérez Lugo, Jannet Trujillo Brito, Francisco Hernández Bernal, Verena Lucila Muzio González, Zurina Cinza Estévez, Joel de la Torre Cruz, Pedro López Saura, Gloria Veliz Rios, Darién Ortega León, Aracelis Blanco Hernández, Aurora Delhanty Fernández, Amaurys del Río Martín, Lester Leal Batista, Bertha L. Batista Marchec, Eduardo Penton Arias
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 35(2)
Manufactures of biotechnological/biological products (including vaccines) frequently make changes to manufacturing processes of products both during development and after approval. In our case, a non-inferiority bridging study was carried out to demo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c50f795674f3da3c224d195d12489969
https://pubmed.ncbi.nlm.nih.gov/17056272
https://pubmed.ncbi.nlm.nih.gov/17056272
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.